Fidelity International
XLO icon

Fidelity International’s Xilio Therapeutics XLO Stock Holding History

Fidelity International’s Portfolio XLO Stock Details XLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-15,622
Closed -$209K – 977
2024
Q4 		$209K Hold
15,622
– – ﹤0.01% 822
2024
Q3 		$172K Hold
15,622
– – ﹤0.01% 831
2024
Q2 		$207K Hold
15,622
– – ﹤0.01% 790
2024
Q1 		$236K Hold
15,622
– – ﹤0.01% 791
2023
Q4 		$120K Hold
15,622
– – ﹤0.01% 767
2023
Q3 		$461K Hold
15,622
– – ﹤0.01% 723
2023
Q2 		$573K Hold
15,622
– – ﹤0.01% 710
2023
Q1 		$695K Hold
15,622
– – ﹤0.01% 732
2022
Q4 		$588K Hold
15,622
– – ﹤0.01% 733
2022
Q3 		$636K Hold
15,622
– – ﹤0.01% 738
2022
Q2 		$639K Hold
15,622
– – ﹤0.01% 742
2022
Q1 		$1.55M Hold
15,622
– – ﹤0.01% 706
2021
Q4 		$3.5M Buy
+15,622
New +$3.72M ﹤0.01% 641

Other funds holding XLO

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return